Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Malignant pleural mesothelioma: update, current management, and newer therapeutic strategies.

Pistolesi M, Rusthoven J.

Chest. 2004 Oct;126(4):1318-29. Review.

PMID:
15486399
2.

Management of malignant pleural mesothelioma.

West SD, Lee YC.

Clin Chest Med. 2006 Jun;27(2):335-54. Review.

PMID:
16716822
3.

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Stahel RA, Weder W, Lievens Y, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v126-8. doi: 10.1093/annonc/mdq173. No abstract available.

4.

Future developments in the management of malignant pleural mesothelioma.

Zucali PA, De Vincenzo F, Simonelli M, Santoro A.

Expert Rev Anticancer Ther. 2009 Apr;9(4):453-67. doi: 10.1586/era.09.2. Review.

PMID:
19374599
5.

Diagnosis and treatment of malignant pleural mesothelioma.

Rodríguez Panadero F.

Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22. Review. English, Spanish.

6.

Malignant pleural mesothelioma.

Ho L, Sugarbaker DJ, Skarin AT.

Cancer Treat Res. 2001;105:327-73. Review.

PMID:
11224994
7.

The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma.

Mairinger F, Vollbrecht C, Mairinger T, Popper H.

J Thorac Oncol. 2013 Aug;8(8):e80-2. doi: 10.1097/JTO.0b013e31829b1cf9. No abstract available.

8.

[Clinicopathological characteristics and prognosis of malignant pleural mesothelioma].

Chen WH, Zhang XL, Dai HP, Tong ZH, Zhang YH, Jin ML.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Nov;36(11):825-8. Chinese.

PMID:
24507393
9.

Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.

Frischknecht L, Meerang M, Soltermann A, Stahel R, Moch H, Seifert B, Weder W, Opitz I.

J Thorac Cardiovasc Surg. 2015 Jun;149(6):1539-46.e1. doi: 10.1016/j.jtcvs.2015.01.065. Epub 2015 Feb 12.

PMID:
25840756
10.

Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma.

Favoni RE, Florio T.

Trends Pharmacol Sci. 2011 Aug;32(8):463-79. doi: 10.1016/j.tips.2011.03.011. Epub 2011 May 26. Review.

PMID:
21620489
11.

[Malignant mesothelioma of the pleura: place of surgery].

Giudicelli R, Regnard JF, Astoul P, Ruffie P.

Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S106-10S109. French. No abstract available.

PMID:
17127980
12.

Pleural mesothelioma.

Astoul P.

Curr Opin Pulm Med. 1999 Jul;5(4):259-68. Review.

PMID:
10407698
13.

Malignant pleural mesothelioma.

Kindler HL.

Curr Treat Options Oncol. 2000 Oct;1(4):313-26. Review.

PMID:
12057157
14.

Malignant pleural mesothelioma: an update on biomarkers and treatment.

Ray M, Kindler HL.

Chest. 2009 Sep;136(3):888-96. doi: 10.1378/chest.08-2665. Review.

PMID:
19736192
15.

The pathology associated with therapeutic procedures in malignant mesothelioma.

Attanoos RL, Gibbs AR.

Histopathology. 2004 Oct;45(4):393-7.

PMID:
15469478
16.

Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose.

Ceresoli GL, Chiti A, Zucali PA, Rodari M, Lutman RF, Salamina S, Incarbone M, Alloisio M, Santoro A.

J Clin Oncol. 2006 Oct 1;24(28):4587-93.

17.

Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.

Bölükbas S, Manegold C, Eberlein M, Bergmann T, Fisseler-Eckhoff A, Schirren J.

Lung Cancer. 2011 Jan;71(1):75-81. doi: 10.1016/j.lungcan.2009.08.019. Epub 2009 Sep 17.

PMID:
19765853
18.

A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.

Kataoka Y, Yamamoto Y, Otsuki T, Shinomiya M, Terada T, Fukuma S, Yamazaki S, Hirabayashi M, Nakano T, Fukuhara S.

Jpn J Clin Oncol. 2015 Jun;45(6):562-8. doi: 10.1093/jjco/hyv039. Epub 2015 Apr 2.

19.

Emerging insights into the biology and therapy of malignant mesothelioma.

Vogelzang NJ.

Semin Oncol. 2002 Dec;29(6 Suppl 18):35-42. Review.

PMID:
12571809
20.

[Malignant pleural mesothelioma: 2013 state of the art].

Campbell K, Brosseau S, Reviron-Rabec L, Bergot E, Lechapt E, Levallet G, Zalcman G.

Bull Cancer. 2013 Dec;100(12):1283-93. doi: 10.1684/bdc.2013.1857. Review. French.

PMID:
24225007
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk